hange is a constant for Emerging Infectious Diseases. Since its inception in 1995, the journal has undergone many transformations: its content has broadened, its format has become more distinctive, and its frequency of publication has increased, from quarterly to bimonthly in 1999 and now to monthly with this issue. Yet, amidst all the changes, Emerging Infectious Diseases has found its niche in the ranks of scientific journals, serving the needs of professionals in infectious diseases and many related disciplines. In 7 short years, the journal has achieved a high impact factor (#3 of 36 infectious disease journals, ISI Citation Reports, 2000) ; indexing in Medline, Current Contents, and other major databases; translations into Spanish, Japanese, Chinese, and French; and a circulation of more than 45,000 subscribers to its print and electronic versions. The journal has also provided a new communication channel through which to encourage global investigation and dialogue on the many issues, challenges, and opportunities posed by emerging infectious diseases.
The goals of the journal stem directly from the Centers for Disease Control and Prevention's (CDC's) action plan against emerging infections: recognition of new and reemerging infections; understanding of factors involved in disease emergence, prevention, and elimination; and fast and broad dissemination of reliable information on emerging infections around the world. Toward these goals, the journal 1) provides information on factors known to influence emergence: microbial adaptation and change, human demographics and behavior, technology and industry, economic development and land use, international travel and commerce, and the breakdown of public health measures; 2) reports laboratory and epidemiologic findings within a broader public health perspective; 3) provides timely updates of infectious disease trends and research (new methods of detecting, characterizing, or subtyping pathogens; developments in antimicrobial drugs, vaccines, and prevention or elimination programs; case reports); 4) publishes reports of interest to researchers in infectious diseases and related sciences, as well as to public health generalists learning the scientific basis for prevention programs; 5) encourages insightful analysis and commentary, stimulating global interest in and discussion of emerging infectious disease issues; and 6) harnesses electronic technology to expedite and enhance global dissemination of emerging infectious disease information.
In pursuing these goals, the journal has set a high standard of quality, not only for its peer-reviewed scientific content but also for the readability and accessibility of this content. A modern journal functions in a fast-paced world of information overload, instant access, overburdened scientific audience, and the accidental broader audience created by the World-Wide Web. To fulfill the increasing expectations of an expanding audience that includes scientists in many disciplines, public health generalists, students, and the public, articles are edited for language, communication effectiveness, style, and length. The human aspect of scientific research is always kept in the forefront by the association of scientific research with works of art on the journal's cover and by "Another Dimension" articles, reminding the reader that, in the end, the purpose of all scientific endeavor is the betterment of humanity and the improvement of the quality of life for all people.
The journal relies on a broad international authorship base and rigorous independent peer review to provide accurate and reliable scientific information on emerging infections, free of charge, around the globe. The journal draws authors and readers from professionals in infectious diseases and many other scientific disciplines in the United States and abroad, specialists in academia, industry, clinical practice, and public health, as well as economics, demography, and sociology. To expedite dissemination of up-to-the-minute information, from its inception Emerging Infectious Diseases has published articles online ahead of print.
Since 1995, Emerging Infectious Diseases has published new scientific research, analysis and commentary, policy reviews, and concise synopses on a broad array of infectious disease topics. Coverage has included topics as diverse as Morbillivirus in Australia, tuberculosis trends in Japan, antimicrobial resistance in Europe, infectious disease emergence in New Zealand, genomics and bacterial pathogenesis, amphibian population declines, the role of migratory birds in the spread of West Nile virus, infections in the health-care setting, bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease, and bioterrorism.
In 
OPPORTUNITIES FOR PEER REVIEWERS
The editors of Emerging Infectious Diseases seek to increase the roster of reviewers for manuscripts submitted by authors all over the world for publication in the journal. If you are interested in reviewing articles on emerging infectious disease topics, please email your name, address, qualifications or curriculum vitae, and areas of expertise to eideditor@cdc.gov At Emerging Infectious Diseases, we always request reviewers' consent before sending manuscripts, limit review requests to three or four per year, and allow 2-4 weeks for completion of reviews. We consider reviewers invaluable in the process of selecting and publishing high-quality scientific articles and acknowledge their contributions in the journal once a year.
Even though it brings no financial compensation, participation in the peer-review process is not without rewards. Manuscript review provides scientists at all stages of their career opportunities for professional growth by familiarizing them with research trends and the latest work in the field of infectious diseases and by improving their own skills for presenting scientific information through constructive criticism of those of their peers. To view the spectrum of articles we publish, information for authors, and our extensive style guide, visit the journal web site at www.cdc.gov/eid .
For more information on participating in the peerreview process of Emerging Infectious Diseases, email eideditor@cdc.gov or call the journal office at 404-371-5329.
International Conference on Emerging Infectious Diseases, 2002
The National Center for Infectious Diseases, Centers for Disease Control and Prevention, has scheduled the Third International Conference on Emerging Infectious Diseases for March [24] [25] [26] [27] 2002 , at the Hyatt Regency Hotel, Atlanta, Georgia, USA. More than 2,500 participants are expected, representing many nations and disciplines. They will discuss the latest information on many aspects of new and reemerging pathogens, such as West Nile virus and issues concerning bioterrorism.
Conference information is available at http://www.cdc.gov/iceid
The Call for Abstracts is available at http://www.asmusa.org/mtgscr/iceido2.htm Contact person is Charles Schable, cas1@cdc.gov
